Robert Desantis Sells 239 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 239 shares of Intuitive Surgical stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $385.55, for a total value of $92,146.45. Following the completion of the transaction, the executive vice president now owns 5,507 shares in the company, valued at approximately $2,123,223.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Robert Desantis also recently made the following trade(s):

• On Monday, May 13th, Robert Desantis sold 284 shares of Intuitive Surgical stock. The shares were sold at an average price of $389.16, for a total value of $110,521.44.
• On Monday, April 29th, Robert Desantis sold 376 shares of Intuitive Surgical stock. The stock was sold at an average price of $375.39, for a total value of $141,146.64.
• On Friday, April 26th, Robert Desantis sold 1,498 shares of Intuitive Surgical stock. The stock was sold at an average price of $369.92, for a total value of $554,140.16.
• On Monday, March 11th, Robert Desantis sold 329 shares of Intuitive Surgical stock. The stock was sold at an average price of $390.16, for a total value of $128,362.64.
• On Friday, March 8th, Robert Desantis sold 20,296 shares of Intuitive Surgical stock. The stock was sold at an average price of $393.80, for a total value of $7,992,564.80.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $399.39 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $403.76. The stock has a 50 day simple moving average of $384.75 and a two-hundred day simple moving average of $356.37. The stock has a market cap of $141.66 billion, a P/E ratio of 72.09, a price-to-earnings-growth ratio of 4.92 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The company had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.00 EPS. Sell-side analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have recently commented on ISRG. Robert W. Baird decreased their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a report on Friday, April 19th. BTIG Research upped their price target on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Barclays boosted their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research report on Thursday, January 25th. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. Finally, Truist Financial upped their price target on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $396.17.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Benchmark Investment Advisors LLC bought a new stake in shares of Intuitive Surgical in the 1st quarter worth $206,000. Waverly Advisors LLC grew its holdings in shares of Intuitive Surgical by 27.1% in the first quarter. Waverly Advisors LLC now owns 2,552 shares of the medical equipment provider’s stock worth $1,018,000 after acquiring an additional 544 shares during the period. Silvercrest Asset Management Group LLC grew its holdings in shares of Intuitive Surgical by 25.0% in the first quarter. Silvercrest Asset Management Group LLC now owns 60,339 shares of the medical equipment provider’s stock worth $24,081,000 after acquiring an additional 12,056 shares during the period. Lavaca Capital LLC bought a new stake in shares of Intuitive Surgical in the first quarter worth $216,000. Finally, London & Capital Asset Management Ltd lifted its position in Intuitive Surgical by 3.0% during the first quarter. London & Capital Asset Management Ltd now owns 59,339 shares of the medical equipment provider’s stock valued at $23,682,000 after purchasing an additional 1,727 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.